Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time-control study

Authors

  • Dorte Kjær,

    Corresponding author
    1. The Danish Epidemiology Science Centre, Department of Epidemiology, Institute of Public Health, University of Aarhus, Aarhus, Denmark
    2. The Centre for Clinical Pharmacology, Department of Pharmacology, University of Aarhus, Aarhus University Hospital, Aarhus, Denmark
    • Danish Epidemiology Science Centre, Institute of Public Health, University of Aarhus, Vennelyst Boulevard 6, DK-8000 Aarhus C, Denmark.
    Search for more papers by this author
  • Erzsébet Horvath-Puhó,

    1. The National Centre of Epidemiology, Budapest, Hungary
    Search for more papers by this author
  • Jakob Christensen,

    1. The Centre for Clinical Pharmacology, Department of Pharmacology, University of Aarhus, Aarhus University Hospital, Aarhus, Denmark
    2. The Department of Neurology, Aarhus University Hospital, Aarhus, Denmark
    Search for more papers by this author
  • Mogens Vestergaard,

    1. The Danish Epidemiology Science Centre, Department of Epidemiology, Institute of Public Health, University of Aarhus, Aarhus, Denmark
    Search for more papers by this author
  • Andrew E. Czeizel,

    1. The Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary
    Search for more papers by this author
  • Henrik Toft Sørensen,

    1. The Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
    2. The Department of Epidemiology, Boston University, MA, USA
    Search for more papers by this author
  • Jørn Olsen

    1. The Danish Epidemiology Science Centre, Department of Epidemiology, Institute of Public Health, University of Aarhus, Aarhus, Denmark
    2. The Department of Epidemiology, School of Public Health, UCLA, Los Angeles, California, USA
    Search for more papers by this author

  • No conflict of interest was declared.

Abstract

Purpose

Case-control studies are often used to examine putative teratogenic drug effects during organogenesis but these studies are subject to confounding by indication, recall, and participation bias. The case-time-control approach is less susceptible to these sources of bias. We studied congenital abnormalities following exposure to phenytoin, phenobarbital, and diazepam in early pregnancy, i.e., second and third month, compared to mid-pregnancy, i.e., fifth and sixth month of pregnancy.

Methods

We analyzed data from the Hungarian Case-Control Surveillance of Congenital Abnormalities (1980–1996) in a case-time-control study.

Results

The study included 22 843 children with congenital abnormalities (cases) and 38 151 children with no abnormalities (controls). Overall, odds ratio (OR) for congenital abnormalities after exposure to one of the three drugs in early pregnancy was 1.2 (95% confidence interval (CI): 1.0–1.4). Among children exposed to phenytoin OR for congenital abnormalities was 3.7 (95%CI: 0.3–49.6), for children exposed to phenobarbital the OR was 1.1 (95%CI 0.7–1.7), and for diazepam, OR for congenital abnormalities was 1.2 (95%CI: 1.0–1.4).

Conclusions

The associations we found between the drugs examined and congenital abnormalities were either only borderline significant or not statistically significant. The case-time-control study provides an interesting way of using existing case-control data to study rare side effect of drugs taken during pregnancy. Copyright © 2006 John Wiley & Sons, Ltd.

Ancillary